BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 14752065)

  • 1. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.
    Krown SE
    J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.
    Nasti G; Tirelli U
    J Clin Oncol; 2005 Apr; 23(10):2433; author reply 2433-4. PubMed ID: 15800341
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly eruptive, treatment-resistant, nodular Kaposi's sarcoma in an acquired immunodeficiency syndrome (AIDS) patient on highly active antiretroviral therapy.
    Chang CA; Sanchez MR; Karen JK; Rosenman KS; Prystowsky SD
    Int J Dermatol; 2009 Feb; 48(2):173-4. PubMed ID: 19200196
    [No Abstract]   [Full Text] [Related]  

  • 5. Kaposi's sarcoma in a nonadherent HAART patient.
    Ball SC
    AIDS Read; 1999; 9(3):170, 173-4. PubMed ID: 12728902
    [No Abstract]   [Full Text] [Related]  

  • 6. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
    AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma in AIDS.
    Volberding PA
    Immunol Ser; 1989; 44():345-58. PubMed ID: 2489116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)].
    Chakib A; Hliwa W; Marih L; Himmich H
    Bull Soc Pathol Exot; 2003 May; 96(2):86-9. PubMed ID: 12836521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments and trials for Kaposi's sarcoma.
    Treat Rev; 1996 Aug; (No 22):11. PubMed ID: 11363814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of AIDS-related Kaposi's sarcoma.
    Di Lorenzo G; Konstantinopoulos PA; Pantanowitz L; Di Trolio R; De Placido S; Dezube BJ
    Lancet Oncol; 2007 Feb; 8(2):167-76. PubMed ID: 17267331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
    J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for AIDS-associated Kaposi's sarcoma.
    Kahn J; Northfelt D; Volberding P
    Oncology (Williston Park); 1991 Oct; 5(10):57-63; discussion 64, 67. PubMed ID: 1838275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count.
    Power DG; Mulholland PJ; O'Byrne KJ
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):97. PubMed ID: 17954026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etiology, pathogenesis and treatment options in Kaposi's sarcoma of HIV infection].
    Simon K
    Przegl Epidemiol; 2001; 55 Suppl 3():129-35. PubMed ID: 11984939
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.